PubRank

Ina Kötter

Author PubWeight™ 35.33‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 2010 2.71
2 Efficacy and safety of rituximab treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitides: results from a German registry (GRAID). J Rheumatol 2012 2.12
3 Long-term remission after cessation of interferon-α treatment in patients with severe uveitis due to Behçet's disease. Arthritis Rheum 2010 1.84
4 Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. Haematologica 2009 1.65
5 Monocyte-derived dendritic cells over-express CD86 in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2006 1.40
6 Identification of multiple independent susceptibility loci in the HLA region in Behçet's disease. Nat Genet 2013 1.34
7 Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID). Arthritis Res Ther 2011 1.23
8 Behçet's disease: ocular effects and treatment. Prog Retin Eye Res 2007 1.17
9 The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis. Eur J Nucl Med Mol Imaging 2011 1.12
10 Nucleosome, the main autoantigen in systemic lupus erythematosus, induces direct dendritic cell activation via a MyD88-independent pathway: consequences on inflammation. J Immunol 2005 1.08
11 MRI findings in inflammatory muscle diseases and their noninflammatory mimics. AJR Am J Roentgenol 2009 0.99
12 Risk factors for severe Muckle-Wells syndrome. Arthritis Rheum 2010 0.98
13 Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a review of the literature. Ann Rheum Dis 2006 0.94
14 Efficacy and safety of willow bark extract in the treatment of osteoarthritis and rheumatoid arthritis: results of 2 randomized double-blind controlled trials. J Rheumatol 2004 0.90
15 Magnetic resonance spin-labeling perfusion imaging of synovitis in inflammatory arthritis at 3.0 T. MAGMA 2009 0.85
16 B cells contribute to heterogeneity of IL-17 producing cells in rheumatoid arthritis and healthy controls. PLoS One 2013 0.83
17 Magnetic resonance imaging findings in patients with systemic scleroderma and musculoskeletal symptoms. Eur Radiol 2012 0.82
18 Interstitial granulomatous dermatitis with arthritis responding to tocilizumab. Arch Dermatol 2012 0.82
19 MRI findings in psoriatic arthritis of the hands. AJR Am J Roentgenol 2010 0.82
20 Anatomic-functional (perfusion-based) magnetic resonance imaging follow-up in patients with rheumatoid arthritis treated with anti-interleukin 6 antibodies: a comparison with clinical scores and serologic data. J Comput Assist Tomogr 2015 0.81
21 Behçet's disease in HLA-B*51 negative Germans and Turks shows association with HLA-Bw4-80I. Arthritis Res Ther 2014 0.81
22 Disseminated epitheloid hemangioendothelioma mimicking symptoms of systemic vasculitis. Onkologie 2005 0.80
23 Response evaluation of musculoskeletal involvement in patients with deep morphea treated with methotrexate and prednisolone: a combined MRI and clinical approach. AJR Am J Roentgenol 2013 0.79
24 The role of dynamic contrast-enhanced MRI in the differential diagnosis of psoriatic and rheumatoid arthritis. AJR Am J Roentgenol 2010 0.79
25 Fertility preservation in women with vasculitis: experiences from the FertiPROTEKT network. Clin Exp Rheumatol 2012 0.79
26 In vivo imaging of cell proliferation enables the detection of the extent of experimental rheumatoid arthritis by 3'-deoxy-3'-18f-fluorothymidine and small-animal PET. J Nucl Med 2012 0.79
27 Increased [11C]PIB-PET levels in inclusion body myositis are indicative of amyloid beta deposition. J Neurol Neurosurg Psychiatry 2010 0.79
28 Treatment of refractory giant cell arteritis with cyclophosphamide:a retrospective analysis of 35 patients from three centres. Clin Exp Rheumatol 2012 0.78
29 Influence of interferon-alpha on lymphocyte subpopulations in Behçet's disease. Adv Exp Med Biol 2003 0.78
30 Imaging of primary and secondary inflammatory diseases involving large and medium-sized vessels and their potential mimics: a multitechnique approach. AJR Am J Roentgenol 2010 0.78
31 Interferon alpha 2a in IRPB-derived peptide-induced EAU--part I. Adv Exp Med Biol 2003 0.78
32 Multifocal ERG changes in patients with ocular Behçet's disease during therapy with interferon alpha 2a. Adv Exp Med Biol 2003 0.76
33 Case report: Successful treatment of cutaneous leishmaniasis caused by Leishmania aethiopica with liposomal amphothericin B in an immunocompromised traveler returning from Eritrea. Am J Trop Med Hyg 2011 0.76
34 Efficacy of pulsed intravenous immunoglobulin therapy in mixed connective tissue disease. J Am Acad Dermatol 2002 0.75
35 Therapeutic implications for interferon-alpha in arthritis. J Rheumatol 2004 0.75
36 The occurrence of Kaposi's sarcoma (KS) in rheumatic diseases. Semin Arthritis Rheum 2004 0.75
37 [Morbus Behçet]. Dtsch Med Wochenschr 2017 0.75
38 Autoantibodies in juvenile idiopathic arthritis: glucose-6-phosphate isomerase is not a specific target. J Rheumatol 2004 0.75
39 TIR-domain-containing adaptor protein gene TIRAP S180L polymorphism is not increased in Behçet's disease patients in two ethnic cohorts. Clin Exp Rheumatol 2013 0.75
40 Behçet's disease: visual acuity after 5 years in patients with alpha-interferon treatment. Adv Exp Med Biol 2003 0.75
41 [56-year-old patient with leg paresis, pulmonary infiltrates, and eosinophilia--Case 08/2009]. Dtsch Med Wochenschr 2009 0.75